SA
RPRX logo
Royalty Pharma plc(RPRX)
Closing price · checked 8:37 PM ETAbout this dataData status
$68.45▲0.73 (1.08%)
Extended:$67.65-0.80 (-1.17%)· 8:37 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Royalty Pharma plc (RPRX)

SBC to Revenue

13.56%

TTM · Retrieved:

RPRX logo

RPRX SBC to Revenue

Current (TTM)13.56%
RPRX SBC/Revenue (0.00% → 13.56%)
Powered by
High-resolution chart · PNG

What is sbc to revenue?

Stock-based compensation as percentage of revenue.

RPRX sbc to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

Royalty Pharma plc SBC to Revenue — Annual fiscal periods
Period endingSBC to RevenueChange
12.1897%+12.09 pts
0.1036%+0.00 pts
0.1001%+0.00 pts
0.097%−0.01 pts
0.1067%−0.15 pts
0.2558%+0.26 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%—

Frequently asked questions: RPRX sbc to revenue

What is Royalty Pharma plc (RPRX)'s current sbc to revenue?

Royalty Pharma plc (RPRX)'s latest reported sbc to revenue (TTM) is 13.56% as of Nov 22, 2026. Stock-based compensation as percentage of revenue.

How much historical sbc to revenue data is available for RPRX?

Stock Alarm Pro provides 11 dated annual fiscal periods observations for Royalty Pharma plc (RPRX)'s sbc to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare RPRX's sbc to revenue to peers or set an alert?

You can open RPRX's sbc to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on RPRX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.